| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.6M | — | +92.2% |
| Cost of Revenue | $4.6M | — | +126.6% |
| Gross Profit | $1.0M | — | +14.8% |
| R&D Expense | $24K | — | +33.3% |
| SG&A Expense | $755K | — | +1.1% |
| Operating Income | -$436K | — | +40.9% |
| Interest Expense | $23K | — | — |
| Net Income | -$661K | — | +13.1% |
| EPS (Basic) | -$0.04 | — | +20.0% |
| EPS (Diluted) | -$0.04 | — | +20.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $2.3M | +16.5% | +52.1% |
| Inventory | $1.8M | +8.4% | +60.0% |
| Current Assets | $6.2M | +45.9% | +28.5% |
| Total Assets | $14.8M | +15.6% | +177.9% |
| Current Liabilities | $5.8M | -47.7% | +135.2% |
| Long-term Debt | $791K | +3.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.4M | — | -370.8% |
| Capital Expenditures | $646K | — | +2207.1% |
| Investing Cash Flow | -$646K | — | -2207.1% |
| Financing Cash Flow | $4.5M | — | +108.5% |
| Free Cash Flow | -$3.0M | — | -467.0% |
| +295.5% |
| Total Liabilities | $13.2M | +14.4% | +416.3% |
| Stockholders' Equity | $1.7M | +26.2% | -39.8% |